Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Shanghai Henlius Biotech, Inc. Proxy Solicitation & Information Statement 2012

Apr 23, 2012

50763_rns_2012-04-22_e4b31df1-a360-4f1c-9eeb-b61eb6d0005c.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

==> picture [85 x 53] intentionally omitted <==

比亞迪股份有限公司 BYD COMPANY LIMITED

(A joint stock company incorporated in the People’s Republic of China with limited liability)

Proxy form for holders of H Shares for use at the Annual General Meeting (“AGM) or any adjournment thereof

I/We (note 1) of (note 1)

being the registered holders of (note 2) H shares in BYD COMPANY LIMITED (the “Company”), HEREBY APPOINT (note 3) the Chairman of the meeting, or

of

or failing him of

as my/our proxy to attend and act for me/us at the Annual General Meeting of the Company (or any adjournment thereof) to be held on Friday, 8 June 2012 at 10:00 a.m. at the Conference Room, No. 3009, BYD Road, Pingshan, Shenzhen, the People’s Republic of China and to vote at such meeting in respect of the resolutions as hereunder indicated, or if no such indication is given, as my/our proxy thinks fit.

Resolutions For
(note 4)
Against
(note 4)
Against
(note 4)
Against
(note 4)
**By ** way of ordinary resolutions:
1. To consider and approve the report of the board of directors of the Company for the year
2011.
2. To consider and approve the report of the supervisory committee of the Company for the
year 2011.
3. To consider and approve the audited financial statements of the Company for the year 2011.
4. To consider and approve annual report of the Company for the year 2011 and the summary
thereof.
5. To consider and approve the profit distribution plan of the Company for the year 2011.
6. To appoint auditors for the financial year of 2012 and to hold office until the conclusion of
the next annual general meeting of the Company, and to authorise the board of directors of
the Company to determine their remuneration.
7. To consider and approve the compliance manual in relation to connected transactions.
8. To consider and approve the compliance manual in relation to independent directors.
9. To consider and approve the management system for the use of funds raised.
10. To consider and approve the rules for the selection and appointment of accountants’ firm.
**By ** way of special resolutions:
11. To consider and approve the provision of guarantee by the Group.
12. To consider and approve the proposed expansion of the scope of business of the Company
by including “acting as the General Distributor of BYD Automobile Co., Ltd. to engage in
the sales, wholesale and exports of passenger vehicles, electric vehicles and their
components under the BYD brand and to provide after-sales services” and “sales of battery
management system, converter cabinet, inverter cabinet/device, junction box, switchboard,
energy storage unit”.
13. To consider and approve the deletion of the existing Article 111 of the Articles of
Association and replacement by “The Company has established the Board of Directors. The
Board of Directors comprises six Directors, with one Chairman and one Vice Chairman.”;
and the addition of the expanded business scope set out in resolution 12 above in Article 11
of the Articles of Association.
14. To consider and approve the rules of procedures of the Shareholders’ General Meetings.
15. To consider and approve the rules of procedures of Meetings of the Board of Directors.
16. To conside and approve the rules of procedures of Meetings of the Supervisory Committee.
Resolutions For
(note 4)
Against
(note 4)
17. To consider and approve:
(a) the grant to the board of directors of the Company (the “Board”) a general mandate
to allot, issue and deal with additional H shares in the capital of the Company
subject to the following conditions:-
(i)
that the H shares allotted, issued and dealt with or agreed conditionally or
unconditionally to be allotted, issued or dealt with by the Board pursuant to
the general mandate shall not exceed 20 per cent of the total H shares in
issue;
(ii)
that the exercise of the general mandate is subject to all
governmental and/or
regulatory approval(s), if any, under the applicable law (including but
without limitation to the Company Law of the PRC and the Rules Governing
the Listing of Securities on The Stock Exchange of Hong Kong Limited);
(iii)
that the general mandate shall remain
valid until the earliest of (x) the
conclusion of the next annual general meeting of the Company; or (y) the
expiration of a 12-month period following the passing of this resolution; or
(z) the date on which the authority set out in this resolution is revoked or
varied by a special resolution of the shareholders of the Company in a
general meeting; and
(b) the authorisation to the Board to approve, execute and do or procure to be executed
and done, all such documents, deeds and things as it may consider necessary in
connection with the allotment and issue of any new shares pursuant to the exercise
of the general mandate referred to in paragraph (a) of this resolution.
18. To consider and approve a general and unconditional mandate to the directors of BYD
Electronic (International) Company Limited (“BYD Electronic”) to allot, issue and otherwise
deal with new shares of BYD Electronic not exceeding 20 per cent. of the aggregate
nominal amount of the issued share capital of BYD Electronic.

Date: Signature(s) (note 5) :

Notes:

  1. Please insert full name(s) and address(es) in block capitals.

  2. Please indicate clearly the number of H shares in the Company registered in your name(s) in respect of which the proxy is so appointed. If no such number is inserted, the proxy will be deemed to be appointed in respect of all the H shares in the Company registered in your name(s).

  3. Where the proxy appointed is not the Chairman of the meeting, please cross out “the Chairman of the meeting”, and fill in the name(s) and address(es) of the proxy in the space provided. Each shareholder is entitled to appoint one or more than one proxy to attend and vote at the meeting on his behalf. The proxy needs not be a member of the Company. The person who signs this proxy form shall initial against any alteration in it.

  4. Important: if you wish to vote for any resolution, tick in the box marked “For”. If you wish to vote against any resolution, tick in the box marked “Against”. Failure to tick any box will entitle your proxy to cast your vote at his discretion.

  5. This form of proxy must be signed by you or your attorney duly authorised in writing (in this case, the power of attorney must be notarially certified) or, in the case of a corporation or institution, either under the corporate seal or under the hand of the chairman of its board of directors or attorney duly authorised in writing.

  6. To be valid, this proxy form and, if such proxy form is signed by a person under a power of attorney or other authority on behalf of the appointor, a notarially certified copy of that power of attorney or other authority (if applicable), must be deposited for the holders of H Shares of the Company at the following address of Computershare Hong Kong Investor Services Limited not less than 24 hours before the time appointed for the holding of the meeting.

Computershare Hong Kong Investor Services Limited’s address is: 17M Floor, Hopewell Centre 183 Queen’s Road East Wanchai Hong Kong

  1. Any alteration made to this proxy form must be initialled by the person(s) who sign it.